DocGo (NASDAQ:DCGO) Releases Earnings Results, Misses Estimates By $0.06 EPS

Posted by on Aug 19th, 2026

DocGo (NASDAQ:DCGO – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06), FiscalAI reports. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%.The business had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million.

Here are the key takeaways from DocGo’s conference call:

  • DocGo agreed to acquire Hicuity Health, a virtual acute- and critical-care provider with approximately $65 million in trailing-12-month revenue and $4.5 million in adjusted EBITDA. Management expects cross-selling opportunities, operational synergies, and a broader hospital-to-home care platform.
  • Perceptive Advisors committed up to $50 million in additional financing, while Hicuity’s existing approximately $52 million of debt will be extended to December 2029. The funding is expected to replace DocGo’s asset-backed credit line and provide greater flexibility for growth.
  • Core business volumes reached records, including year-over-year gains of 15% in U.S. medical transportation, 26% in healthcare at home, 20% in mobile phlebotomy, and 58% in virtual care and lab orders. Excluding migrant-related revenue and the SteadyMD acquisition, organic revenue still grew approximately 5% year over year.
  • Efficiency initiatives are beginning to reduce costs, with the adjusted EBITDA loss improving nearly 40% sequentially to $6.3 million and a corporate reduction in force expected to lower annual SG&A by about $4.5 million. DocGo estimates approximately $6 million in additional annual savings from AI and other efficiency programs once fully implemented.
  • DocGo widened its 2026 adjusted EBITDA loss guidance to $17 million-$22 million from $5 million-$10 million, citing weaker-than-expected margins and delayed cost-cutting benefits. Total cash and equivalents declined to $48.1 million at quarter-end, while revenue remained pressured by the wind-down of migrant-related projects.

DocGo Price Performance

DocGo stock opened at $0.48 on Wednesday. The stock has a fifty day moving average price of $0.60 and a two-hundred day moving average price of $0.64. DocGo has a 52-week low of $0.45 and a 52-week high of $1.73. The firm has a market capitalization of $46.93 million, a P/E ratio of -0.24 and a beta of 0.99.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on DCGO. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Needham & Company LLC reissued a “buy” rating and set a $3.00 target price on shares of DocGo in a research report on Tuesday. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of DocGo in a research report on Monday, May 11th. Wall Street Zen upgraded DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Canaccord Genuity Group reiterated a “hold” rating and set a $1.00 price target on shares of DocGo in a report on Tuesday. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $2.38.

View Our Latest Stock Report on DocGo

Institutional Investors Weigh In On DocGo

Large investors have recently made changes to their positions in the company. Empowered Funds LLC lifted its holdings in DocGo by 14.6% during the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock valued at $121,000 after purchasing an additional 17,607 shares during the last quarter. Boothbay Fund Management LLC increased its holdings in DocGo by 39.0% during the 4th quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock valued at $176,000 after purchasing an additional 56,413 shares in the last quarter. Bridgeway Capital Management LLC raised its position in DocGo by 45.5% in the 4th quarter. Bridgeway Capital Management LLC now owns 539,306 shares of the company’s stock valued at $473,000 after purchasing an additional 168,607 shares during the last quarter. Jain Global LLC acquired a new position in DocGo in the fourth quarter worth $70,000. Finally, Public Employees Retirement System of Ohio bought a new position in shares of DocGo in the fourth quarter valued at about $40,000. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Featured Stories

Earnings History for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.